Atlas Trials

ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab

Clinical trial NCT04272463 · COMPLETED

Trial details

NCT number
NCT04272463
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Severe Asthma
Start date
2020-03-13
Primary completion
2020-07-15
Enrollment
217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.